BACKGROUND AIMS: Non-irradiated immunodeficient recipients provide the best physiologic setting for revealing hematopoietic stem cell (HSC) functions after xenotransplantion. An approach that efficiently permits the detection of human hematopoietic repopulating cells in non-irradiated recipients is therefore highly desired. METHODS: We compared side-by-side the ability to reconstitute hematopoiesis via intra-bone marrow transplantation (IBMT) in three commonly used mouse strains avoiding previous irradiation. RESULTS: Non-irradiated NOD/SCID and NOD/SCID (beta2m-/- mouse strains prevent engraftment even after IBMT. In contrast, combining the robustness of the NOD/SCID IL-2Rgamma-/- recipient with the sensitivity of IBMT facilitates the detection, without previous host irradiation, of human SCID-repopulating cells 10 weeks after transplantation. The level of chimerism averaged 14% and multilineage engraftment (lymphoid dominant) was observed consistently in all mice. Analysis of injected and non-injected bones, spleen and peripheral blood demonstrated that engrafting cells were capable of in vivo migration and expansion. CONCLUSIONS: Combining the robustness of the NOD/SCID IL-2Rgamma-/- mouse strain with the sensitivity of IBMT strongly facilitates long-term multilineage engraftment and migration for human CD34(+) cells without the need for previous irradiation.
BACKGROUND AIMS: Non-irradiated immunodeficient recipients provide the best physiologic setting for revealing hematopoietic stem cell (HSC) functions after xenotransplantion. An approach that efficiently permits the detection of human hematopoietic repopulating cells in non-irradiated recipients is therefore highly desired. METHODS: We compared side-by-side the ability to reconstitute hematopoiesis via intra-bone marrow transplantation (IBMT) in three commonly used mouse strains avoiding previous irradiation. RESULTS: Non-irradiated NOD/SCID and NOD/SCID (beta2m-/- mouse strains prevent engraftment even after IBMT. In contrast, combining the robustness of the NOD/SCID IL-2Rgamma-/- recipient with the sensitivity of IBMT facilitates the detection, without previous host irradiation, of humanSCID-repopulating cells 10 weeks after transplantation. The level of chimerism averaged 14% and multilineage engraftment (lymphoid dominant) was observed consistently in all mice. Analysis of injected and non-injected bones, spleen and peripheral blood demonstrated that engrafting cells were capable of in vivo migration and expansion. CONCLUSIONS: Combining the robustness of the NOD/SCID IL-2Rgamma-/- mouse strain with the sensitivity of IBMT strongly facilitates long-term multilineage engraftment and migration for humanCD34(+) cells without the need for previous irradiation.
Authors: Damia Romero-Moya; Clara Bueno; Rosa Montes; Oscar Navarro-Montero; Francisco J Iborra; Luis Carlos López; Miguel Martin; Pablo Menendez Journal: Haematologica Date: 2013-01-24 Impact factor: 9.941
Authors: Clara Bueno; Rosa Montes; Gustavo J Melen; Verónica Ramos-Mejia; Pedro J Real; Verónica Ayllón; Laura Sanchez; Gertrudis Ligero; Iván Gutierrez-Aranda; Agustín F Fernández; Mario F Fraga; Inmaculada Moreno-Gimeno; Deborah Burks; María del Carmen Plaza-Calonge; Juan C Rodríguez-Manzaneque; Pablo Menendez Journal: Cell Res Date: 2012-01-03 Impact factor: 25.617
Authors: Michael A Brehm; Waldemar J Racki; Jean Leif; Lisa Burzenski; Vishnu Hosur; Amber Wetmore; Bruce Gott; Mary Herlihy; Ronald Ignotz; Raymond Dunn; Leonard D Shultz; Dale L Greiner Journal: Blood Date: 2012-01-12 Impact factor: 22.113
Authors: Ivan Gutierrez-Aranda; Veronica Ramos-Mejia; Clara Bueno; Martin Munoz-Lopez; Pedro J Real; Angela Mácia; Laura Sanchez; Gertrudis Ligero; Jose L Garcia-Parez; Pablo Menendez Journal: Stem Cells Date: 2010-09 Impact factor: 6.277
Authors: Clara Bueno; Mar Roldan; Eduardo Anguita; Damia Romero-Moya; Beatriz Martín-Antonio; Michael Rosu-Myles; Consuelo del Cañizo; Francisco Campos; Regina García; Maite Gómez-Casares; Jose Luis Fuster; Manuel Jurado; Mario Delgado; Pablo Menendez Journal: Haematologica Date: 2014-04-11 Impact factor: 9.941
Authors: R Montes; V Ayllón; C Prieto; A Bursen; C Prelle; D Romero-Moya; P J Real; O Navarro-Montero; C Chillón; R Marschalek; C Bueno; P Menendez Journal: Leukemia Date: 2013-11-18 Impact factor: 11.528
Authors: Malte von Bonin; Martin Wermke; Kadriye Nehir Cosgun; Christian Thiede; Martin Bornhauser; Gerard Wagemaker; Claudia Waskow Journal: PLoS One Date: 2013-04-09 Impact factor: 3.240